新型五环三萜类PI3K抑制剂的设计及虚拟活性筛选

参考文献张正,张莉芳,刘彦廷,等.《2022全球癌症统计报告》解读[J].中国医院统计,2024,31(05):393-400.金心怡,张颖,钟悦欣,马爽.1990-2021年中国和全球恶性肿瘤疾病负担变化趋势和预测分析[J].解放军医学杂志,1-15.RusnatiM,PrestaM.Fibroblastgrowthfactors/fibroblastgrowthfactorreceptorsastargetsforthedevelopmentofanti-angiogenesisstrategies[J].CurrentPharmaceuticalDesign,2007,13(20):22-24.MountfordSJ,ZhengZ,SundaramK,etal.ClassIIbutNotSecondClass-ProspectsfortheDevelopmentofClassIIPI3KInhibitors[J].ACSMedicinalChemistryLetters,2014,6(1):3-6.VivancoI,SawyersCL.Thephosphatidylinositol3-kinaseAKTpathwayinhumancancer[J].NatureReviewsCancer,2002,2(7):489-501.FalascaM,HamiltonJR,SelvaduraiM,etal.ClassIIPhosphoinositide3-KinasesasNovelDrugTargets[J].JournalofMedicinalChemistry,2017,60(1):47-65.张凯敏,黄玉洁,段莹,等.PI3K抑制剂林普利塞对弥漫大B细胞淋巴瘤的体外抗肿瘤效应[J].中国癌症防治杂志,2024,16(01):56-61.花靖棋,沈华,邓君鹏.PI3K/Akt/mTOR信号通路抑制剂在肾癌治疗中的应用进展[J].山东医药,2023,63(36):107-111．WILSONJM，KUNNIMALAIYANS，GAMBLINTC，etal．MK2206inhibitshepatocellularcarcinomacellularproliferationviainductionofapoptosisandcellcyclearrest[J].JSurgRes,2014,191(2):280-285．ZHAIB,ZHANGX,SUNB,etal.MK2206overcomestheresistanceofhumanlivercancerstemcellstosorafenibbyinhibitionofpAktandupregulationofpERK[J].TumourBiol,2016,37(6):8047-8055．WALLINJJ,GUANJ,PRIORWW,etal.GDC-0941,anovelclassIselectivePI3Kinhibitor,enhancestheefficacyofdocetaxelinhumanbreastcancermodelsbyincreasingcelldeathinvitroandinvivo[J].ClinCancerRes,2012,18(14):3901-3911．ZOUZQ,ZHANGLN,WANGF,etal.ThenoveldualPI3K/mTORinhibitorGDC-0941synergizeswiththeMEKinhibitorU0126innon-smallcelllungcancercells[J].MolMedReport,2012,5(2):503-508．ChenJ.Editorial(hottopic:potentialvalueandlimitationofdualinhibitorsofPI3KandmTORinthetreatmentofcancer)[J].CurrentCancerDrugTargets,2013,13(2):117-120.LapoA,BethC,RobertAB.Noveltargetedtherapiesformant-lecelllymphoma[J].Oncotarget,2012,3(2):203-211.NathanTI,GarthP.Inhibitorsofphosphatidylinositol-3-kinaseincancertherapy[J].MolAspectsMed,2010,31(2):135-144.XuG,YuanG,LuX,etal.StudyontheeffectofregulationofCordycepsmilitarispolypeptideontheimmunefunctionofmicebasedonatranscriptionfactorregulatorynetwork[J].FoodandFunction,2020,11(7):6066-6077.杜贵强,张永莉,胡孝辉.齐墩果酸对人卵巢癌SKOV3细胞增殖、侵袭、转移的影响及其作用机制研究[J].中国药房,2020,31(10):1190-1196.孙阳,孙悦,吴勃岩,等.齐墩果酸诱导肝癌细胞凋亡的实验研究[J].中医药学报,2022,49(11):33－37.徐立,王冲.齐墩果酸抗糖尿病的研究进展与展望[J].中国实验方剂学杂志,2018,24(8):228－234.Xiao-LiWan,Yuan-FuLu,Shang-FuXu,etal.OeanolicacidprotectsagainstthehepatotoxicityofD-galactosameplusendotoxininmice.Biomedicine＆Pharmacotherapy,2017,93:1040-1046.JoséMCastellano,SaraRamos-Romero,JavierSPero-na.OleanolicAcid:Extraction,CharacterizationandBiologi-calActivity[J].Nutrients,2022,14(3):623.张蓬勃,宋艳玲．齐墩果酸衍生物的合成及其抗癌活性的研究[J].沈阳化工大学学报,2021,35(1)：25-29．WangSS,ZhangQL,ChuP,etal.Synthesisandantitumoractivityofα,β-unsaturatedcarbonylmoiety-containingoleanolicacidderivativestargeting2020,101:PI3K/AKT/mTORsignalingpathway[J].BioorganicChemistry,104036-104064.杨姝萸.齐墩果酸A环及C-28位衍生物的合成及抗肿瘤活性研究[D].沈阳化工大学,2022.LiY,TianK,QinA,etal.Discoveryofnovelureaderivativesasdual-targethypoglycemicagentsthatactivateglucokinaseandPPARγ[J].EuropeanJournalofMedicinalChemistry,2014,76:182-192.BrownJR,NorthEJ,HurdleJG,etal.Thestructure-activityrelationshipofureaderivativesasanti-tuberculosisagents[J].BioorganicandMedicinalChemistry,2011,19(18):5585-5595.王将.新型酰基(硫)脲类衍生物的合成及生物活性研究[D].青岛科技大学,2022.李欢,康博瑞,张三奇．苯并噻唑衍生物抗肿瘤活性研究进展[J].中国药物化学杂志,2014,24(06)：484-492．李俊毅,李文青,高升华,等.计算机辅助药物设计在抗病毒药物研究中的应用[J].中国药物化学杂志,2023,33(12):930-947.PinziL,RastelliG.MolecularDocking:ShiftingPara